These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 18825962)
1. [Methylation of promoter region of RAR-beta2 gene in renal cell, breast, and ovarian carcinomas]. Khodyrev DS; Loginov VI; Pronina IV; Kazubskaia TP; Gar'kavtseva RF; Braga EA Genetika; 2008 Aug; 44(8):1126-32. PubMed ID: 18825962 [TBL] [Abstract][Full Text] [Related]
2. An EGF receptor inhibitor induces RAR-beta expression in breast and ovarian cancer cells. Grunt TW; Puckmair K; Tomek K; Kainz B; Gaiger A Biochem Biophys Res Commun; 2005 Apr; 329(4):1253-9. PubMed ID: 15766561 [TBL] [Abstract][Full Text] [Related]
3. Hypermethylation does not account for the frequent loss of the retinoic acid receptor beta2 in breast carcinoma. Yang Q; Sakurai T; Yoshimura G; Mori I; Nakamura M; Nakamura Y; Suzuma T; Tamaki T; Umemura T; Kakudo K Anticancer Res; 2001; 21(3B):1829-33. PubMed ID: 11497266 [TBL] [Abstract][Full Text] [Related]
4. RAR beta2 suppression in head and neck squamous cell carcinoma correlates with site, histology and age. Olasz J; Juhász A; Remenár E; Engi H; Bak M; Csuka O; Kásler M Oncol Rep; 2007 Jul; 18(1):105-12. PubMed ID: 17549354 [TBL] [Abstract][Full Text] [Related]
5. Wnt signalling in human breast cancer: expression of the putative Wnt inhibitor Dickkopf-3 (DKK3) is frequently suppressed by promoter hypermethylation in mammary tumours. Veeck J; Bektas N; Hartmann A; Kristiansen G; Heindrichs U; Knüchel R; Dahl E Breast Cancer Res; 2008; 10(5):R82. PubMed ID: 18826564 [TBL] [Abstract][Full Text] [Related]
6. [Relationship between RAR-beta gene expression defect and its methylation]. Gao YP; Li M; Zhang YY; Wang H; He XH; Wang ZH Zhonghua Fu Chan Ke Za Zhi; 2007 Jul; 42(7):472-6. PubMed ID: 17961338 [TBL] [Abstract][Full Text] [Related]
7. Methylation of the retinoid response gene TIG1 in prostate cancer correlates with methylation of the retinoic acid receptor beta gene. Zhang J; Liu L; Pfeifer GP Oncogene; 2004 Mar; 23(12):2241-9. PubMed ID: 14691453 [TBL] [Abstract][Full Text] [Related]
8. Silencing and re-expression of retinoic acid receptor beta2 in human melanoma. Fan J; Eastham L; Varney ME; Hall A; Adkins NL; Chetel L; Sollars VE; Georgel P; Niles RM Pigment Cell Melanoma Res; 2010 Jun; 23(3):419-29. PubMed ID: 20374520 [TBL] [Abstract][Full Text] [Related]
10. Promoter hypermethylation of the SFRP2 gene is a high-frequent alteration and tumor-specific epigenetic marker in human breast cancer. Veeck J; Noetzel E; Bektas N; Jost E; Hartmann A; Knüchel R; Dahl E Mol Cancer; 2008 Nov; 7():83. PubMed ID: 18990230 [TBL] [Abstract][Full Text] [Related]
11. Loss of retinoic acid receptor beta expression in breast cancer and morphologically normal adjacent tissue but not in the normal breast tissue distant from the cancer. Widschwendter M; Berger J; Daxenbichler G; Müller-Holzner E; Widschwendter A; Mayr A; Marth C; Zeimet AG Cancer Res; 1997 Oct; 57(19):4158-61. PubMed ID: 9331065 [TBL] [Abstract][Full Text] [Related]
12. [Activation of RHOA gene transcription in epithelial tumors may be caused by gene amplification and/or demethylation of its promotor region]. Braga EA; Loginov VI; Klimov EA; Kilosanidze G; Khodyrev DS; Kaganova NL; Kazybskaia TP; Ermilova VD; Gar'kavtseva RF; Pronina IV; Rud'ko OI; Zabarskiĭ ER; Sulimova GE; Kiselev LL Mol Biol (Mosk); 2006; 40(5):865-77. PubMed ID: 17086988 [TBL] [Abstract][Full Text] [Related]
13. [Methylation of promoter region of RASSF1A gene and frequencies of allelic imbalances in chromosome 3 critical regions are correlated with progression of clear cell renal cell carcinoma]. Loginov VI; Khodyrev DS; Pronina IV; Kazubskaia TP; Ermilova VD; Gar'kavtseva RF; Braga EA Mol Biol (Mosk); 2009; 43(3):429-38. PubMed ID: 19548529 [TBL] [Abstract][Full Text] [Related]
14. A novel RARbeta isoform directed by a distinct promoter P3 and mediated by retinoic acid in breast cancer cells. Peng X; Maruo T; Cao Y; Punj V; Mehta R; Das Gupta TK; Christov K Cancer Res; 2004 Dec; 64(24):8911-8. PubMed ID: 15604252 [TBL] [Abstract][Full Text] [Related]
15. Retinoic acid receptor beta2 is epigenetically silenced either by DNA methylation or repressive histone modifications at the promoter in cervical cancer cells. Zhang Z; Joh K; Yatsuki H; Zhao W; Soejima H; Higashimoto K; Noguchi M; Yokoyama M; Iwasaka T; Mukai T Cancer Lett; 2007 Mar; 247(2):318-27. PubMed ID: 16806674 [TBL] [Abstract][Full Text] [Related]
16. Up-regulation of retinoic acid receptor beta expression in renal cancers in vivo correlates with response to 13-cis-retinoic acid and interferon-alpha-2a. Berg WJ; Nanus DM; Leung A; Brown KT; Hutchinson B; Mazumdar M; Xu XC; Lotan R; Reuter VE; Motzer RJ Clin Cancer Res; 1999 Jul; 5(7):1671-5. PubMed ID: 10430067 [TBL] [Abstract][Full Text] [Related]
17. Methylation and silencing of the retinoic acid receptor-beta 2 gene in cervical cancer. Ivanova T; Petrenko A; Gritsko T; Vinokourova S; Eshilev E; Kobzeva V; Kisseljov F; Kisseljova N BMC Cancer; 2002 Mar; 2():4. PubMed ID: 11945179 [TBL] [Abstract][Full Text] [Related]
18. Promoter hypermethylation of the retinoic acid receptor beta2 gene is frequent in acute myeloid leukaemia and associated with the presence of CBFbeta-MYH11 fusion transcripts. Rethmeier A; Aggerholm A; Olesen LH; Juhl-Christensen C; Nyvold CG; Guldberg P; Hokland P Br J Haematol; 2006 May; 133(3):276-83. PubMed ID: 16643429 [TBL] [Abstract][Full Text] [Related]
19. Hypermethylation in promoter region of retinoic acid receptor-beta gene and immunohistochemical findings on retinoic acid receptors in carcinogenesis of endometrium. Li R; Saito T; Tanaka R; Satohisa S; Adachi K; Horie M; Akashi Y; Kudo R Cancer Lett; 2005 Feb; 219(1):33-40. PubMed ID: 15694662 [TBL] [Abstract][Full Text] [Related]
20. Microvessel density and CpG island methylation of the THBS2 gene in malignant ovarian tumors. Czekierdowski A; Czekierdowska S; Danilos J; Czuba B; Sodowski K; Sodowska H; Szymanski M; Kotarski J J Physiol Pharmacol; 2008 Sep; 59 Suppl 4():53-65. PubMed ID: 18955754 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]